About: Biologie moléculaire et microbiologie clinique en 2007 Les applications et leur avenir

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Biologie moléculaire et microbiologie clinique en 2007 Les applications et leur avenir – Partie 2 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Biologie moléculaire et microbiologie clinique en 2007 Les applications et leur avenir – Partie 2
Creator	Ameziane, N Bogard, M Bouizegarène, P Deybach, J.-C Lamoril, J
Source	Elsevier; PMC
abstract	Résumé La biologie moléculaire est omniprésente en biologie médicale et plus particulièrement en microbiologie. De nombreux articles démontrent son importance tant dans le domaine du diagnostic que du pronostic, de l'évaluation thérapeutique, de l'épidémiologie ou des risques biologiques naturels ou non. La quantité considérable d'articles sur ce sujet n'apporte pas toujours une réponse évidente sur le rôle de la biologie moléculaire dans un laboratoire de microbiologie qu'il soit hospitalier ou non. Cette revue constitue une synthèse des apports de cette discipline en microbiologie. À partir de cet état des lieux, certaines questions se posent, par exemple: la biologie moléculaire constitue-t-elle un réel apport en microbiologie? Dans quelles indications prescrire un examen de biologie moléculaire? Les réponses ne sont pas toujours simples. Elles sont évidentes dans certains cas (l'hépatite C par exemple) et le sont moins dans d'autres, la tuberculose par exemple. Dans la première partie de l'article, nous avons parlé des généralités appliquées à la microbiologie. Dans cette deuxième partie, nous abordons certaines applications, reflets de l'importance prise par la biologie moléculaire en microbiologie. Abstract Molecular biology is omnipresent in medical biology especially in microbiology. Many papers report studies on its importance in diagnosis, prognosis, therapeutic field, epidemiology, natural (or not) biological risks alike. The important sum of reports on this subject does not always bring an obvious answer to the part that molecular biology could play in a microbiology laboratory either public or private. This article summarizes the contributions of this specialized field in microbiology and brings some questions on its contribution. Is molecular biology a real progress in microbiology? What are the main indications of molecular biology today in this field? According to the infectious particle, the answers are not always simple. They can be obvious in some cases (for instance, hepatitis C) or less obvious in other cases (tuberculosis for instance). In the first part of this article, we reported general remarks in molecular biology related to microbiology. The second part report some important applications underlining the important extent of molecular biology in this field.
has issue date	2007-04-30(xsd:dateTime)
bibo:doi	10.1016/j.immbio.2006.11.002
has license	els-covid
sha1sum (hex)	7b425749127b05ad3c800bc1d2aff613a0ee4810
schema:url	https://doi.org/10.1016/j.immbio.2006.11.002
resource representing a document's title	Biologie moléculaire et microbiologie clinique en 2007 Les applications et leur avenir – Partie 2
has PubMed Central identifier	PMC7148721
schema:publication	Immuno-analyse & Biologie Spécialisée
resource representing a document's body	covid:7b425749127b05ad3c800bc1d2aff613a0ee4810#body_text
is schema:about of	named entity 'leur' named entity 'SUR' named entity 'APPLICATIONS' named entity 'MOL' named entity 'CLINICAL MICROBIOLOGY' named entity 'MOLECULAR BIOLOGY' named entity 'MICROBIOLOGIE' named entity 'LES' named entity 'INTERNET' named entity 'AMPLIFICATION' named entity 'MICROBIOLOGIE' named entity 'MOL' named entity 'biology' named entity '2007' named entity 'clinique' named entity 'PCR' named entity 'Smiths Detection' named entity 'permet' named entity 'mycoses' named entity 'le Tableau' named entity 'la cible' named entity 'dont' named entity 'Escherichia coli' named entity 'revanche' named entity 'strand displacement amplification' named entity 'permet' named entity 'mois' named entity 'permet' named entity 'centrifugation' named entity 'la résistance' named entity 'Giardia' named entity 'permet' named entity 'fluoroquinolone' named entity 'la brousse' named entity 'PCR' named entity 'infection' named entity 'Cryptosporidium' named entity 'Francisella tularensis' named entity 'dont' named entity 'permis' named entity 'le temps' named entity 'infection' named entity 'GeneXpert' named entity 'États-Unis' named entity 'PCR' named entity 'permet' named entity 'infection' named entity 'la cible' named entity 'PCR' named entity 'infection' named entity 'Celle' named entity 'États-Unis' named entity 'Trichomonas' named entity 'PCR' named entity 'circulant' named entity 'Le Tableau' named entity 'smallpox virus' named entity 'Brucella' named entity 'PCR' named entity 'syphilis' named entity 'infection' named entity 'En dehors' named entity 'la cible' named entity 'infection' named entity 'centrifugation' named entity 'Clostridium botulinum' named entity 'mycoses' named entity 'infection' named entity 'dont' named entity 'PCR' named entity 'Candida albicans' named entity 'Toxoplasma gondii' named entity 'isoniazide' named entity 'sondes' named entity 'cryptococcus' named entity 'mois' named entity 'PCR' named entity 'CD4' named entity 'permet'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software